Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Skin Cancer Channel is supported with funding from Iovance Biotherapeutics (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

ESMO 2021 | ST101: targeting C/EBPβ in patients with advanced solid tumors

Meredith A. McKean, MD, MPH, Sarah Cannon Research Institute, Nashville, TN, discusses the efficacy, safety and pharmacokinetic and pharmacodynamic data from a Phase I dose-escalation study of a novel therapeytic peptide, ST101, targeting the oncogenic transcription factor C/EBPβ, in patients with advanced and metastatic solid tumors. ST101 has been demonstrated to induce selective cancer cell cytotoxicity across a variety of tumor types, including but not limited to breast cancer, melanoma, prostate cancer, GBM, lung cancer, and acute myeloid leukemia. This interview took place at the European Society for Medical Oncology (ESMO) 2021 congress.

Disclosures

Dr McKean reports research grants paid to Institution from Acentage Pharma Group, Bicycle Therapeutics, Dragonfly Therapeutics, Epizyme, Exelixis, Genentech, GlaxoSmithKline, IDEAYA Biosciences, Ikena Oncology, Infinity Pharmaceuticals, Jacobio Pharmaceuticals, Moderna, NBE Therapeutics, Novartis, Oncorus, Plexxikon, Prelude Therapeutics, Regeneron, Sapience Therapeutics, Seattle Genetics, Tizona Therapeutics, TMUNITY Therapeutics, TopAlliance Biosciences, Bayer, BioMed Valley Discoveries, EMD Serono, MedImmune, Nektar Therapeutics, Pfizer, Teneobio, Arvinas, Tempest Therapeutics, Arcus Biosciences, Synthrox, Alpine Immune, Scholar Rock, BioNTech, Erasca, Kechow Pharma, Mereo BioPharma, Foghorn Therapeutics, Pyramid Biosciences, PACT pharma, ImmVira Pharma, Kinnate Biopharma, Metabomed/

Dr McKean reports consulting/advisory roles from Array BioPharma, AstraZeneca, MedPage Today, Pfizer, Regeneron Pharmaceuticals, Astellas Pharma, BicycleTx Limited, Castle Biosciences, Ideaya Biosciences, iTeos.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.